DAVID GREEN - 12 May 2022 Form 4 Insider Report for Biostage, Inc. (HRGN)

Role
Interim CEO, Director
Signature
/s/ Chad Porter, by power of attorney
Issuer symbol
HRGN
Transactions as of
12 May 2022
Net transactions value
+$375,002
Form type
4
Filing time
23 May 2022, 14:45:54 UTC
Previous filing
30 Nov 2021
Next filing
27 Jan 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BSTG Common Stock Purchase $375,002 +63,345 +66% $5.92 158,861 12 May 2022 Direct F1
holding BSTG Common Stock 16,468 12 May 2022 2018 Biostage GRAT

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BSTG Warrants (right to buy) Purchase +31,673 31,673 12 May 2022 Common Stock 31,673 $8.88 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On May 12, 2022, the Issuer and the Reporting Person entered into 2 securities purchase agreements (the "Purchase Agreement") pursuant to which the Reporting Person acquired from the Issuer in a private placement: (i) 63,345 shares of the Issuer's common stock, $0.01 par value (collectively, the "Shares"); and (ii) warrants to purchase up to 31,673 shares of common stock with an exercise price of $8.88 per share (the "Warrants"). The aggregate subscription amount paid by the Reporting Person for the Shares and Warrants acquired by it pursuant to the Purchase Agreements was $375,000.

Remarks:

This form has been signed under power of attorney.